0002038883-24-000001.txt : 20241021 0002038883-24-000001.hdr.sgml : 20241021 20241021130639 ACCESSION NUMBER: 0002038883-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241021 DATE AS OF CHANGE: 20241021 EFFECTIVENESS DATE: 20241021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hubble Therapeutics, LLC CENTRAL INDEX KEY: 0002038883 ORGANIZATION NAME: IRS NUMBER: 852061547 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-527330 FILM NUMBER: 241382678 BUSINESS ADDRESS: STREET 1: 35 SOUTH MAIN STREET CITY: HANOVER STATE: NH ZIP: 03755 BUSINESS PHONE: (617) 780-2375 MAIL ADDRESS: STREET 1: 35 SOUTH MAIN STREET CITY: HANOVER STATE: NH ZIP: 03755 D 1 primary_doc.xml X0708 D LIVE 0002038883 Hubble Therapeutics, LLC 35 SOUTH MAIN STREET HANOVER NH NEW HAMPSHIRE 03755 (617) 780-2375 DELAWARE None None Limited Liability Company true 2020 Jeff Sabados 35 South Main Street Hanover NH NEW HAMPSHIRE 03755 Executive Officer Director Greg Keenan 35 South Main Street Hanover NH NEW HAMPSHIRE 03755 Director Sam Goldberger 35 South Main Street Hanover NH NEW HAMPSHIRE 03755 Director Biotechnology Decline to Disclose 06b false 2024-10-09 false true false 0 11107697 9807697 1300000 false 17 0 0 0 false Hubble Therapeutics, LLC /s/ Jeff Sabados Jeff Sabados Chief Executive Officer 2024-10-21